Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Cryo Cell International (CCEL) over the last 15 years, with Q3 2025 value amounting to $103000.0.

  • Cryo Cell International's Gains from Investment Securities changed 0.0% to $103000.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $103000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $113600.0 for FY2024, which is 809.06% down from last year.
  • Cryo Cell International's Gains from Investment Securities amounted to $103000.0 in Q3 2025, which was down 0.0% from $103000.0 recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Gains from Investment Securities registered a high of $1.6 million during Q4 2021, and its lowest value of -$431599.0 during Q2 2021.
  • Over the past 5 years, Cryo Cell International's median Gains from Investment Securities value was $103000.0 (recorded in 2024), while the average stood at $169103.3.
  • In the last 5 years, Cryo Cell International's Gains from Investment Securities tumbled by 167385.77% in 2021 and then surged by 288604.27% in 2025.
  • Quarter analysis of 5 years shows Cryo Cell International's Gains from Investment Securities stood at $1.6 million in 2021, then plummeted by 88.02% to $195469.0 in 2022, then skyrocketed by 61.74% to $316155.0 in 2023, then grew by 4.98% to $331897.0 in 2024, then tumbled by 68.97% to $103000.0 in 2025.
  • Its Gains from Investment Securities stands at $103000.0 for Q3 2025, versus $103000.0 for Q2 2025 and $331897.0 for Q4 2024.